Practical applications of deep learning to impute heterogeneous drug discovery data
This article outlines practical applications of deep learning on drug discovery data. It introduces some of the research behind our…
To become a successful drug, our active molecule must also display excellent pharmacokinetic (PK) properties, however experimental data on PK parameters can be difficult to come by.
In our previous webinar, Predicting Pharmacokinetic Parameters and Curves we explored a proof-of-concept example of how deep learning imputation can help us to accurately predict PK, even when we may not have much experimental data.
Now, watch Matt Segall, PhD, CEO at Optibrium, as he introduces a real world case study where we applied deep learning to guide a project, in which potential compounds were displaying good activity profiles but the team wanted to improve their PK profile to achieve better efficacy.
Find out more about:
- The challenges we face in using data in drug discovery
- What deep learning imputation is, and how it works in the context of PK
- Real life case studies of deep learning in action for PK prediction, and how our collaborators have found success using these methods
- Optibrium’s Cerella AI drug discovery software
Introducing our webinar speaker
Matt Segall, PhD
CEO, Optibrium
More AI-guided resources
Cerella™: Reduce the time and cost of your discovery cycles with deep learning
In this webinar, we demonstrate how Cerella™ (AI drug discovery software) highlights new opportunities and guides more efficient compound optimisation.
The power of AI applied to agrochemical bioactivity
In the face of growing agrochemical resistance and increasingly stringent regulatory requirements, how can artificial intelligence (AI) be harnessed to help lower the costs, failure rates and timelines associated with current agrochemical development cycles?
